As of April 2024 Pulse Biosciences has a market cap of $0.36 Billion. This makes Pulse Biosciences the world's 6298th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.36 B | -45.2% |
2023 | $0.67 B | 553.77% |
2022 | $0.10 B | -76.5% |
2021 | $0.43 B | -27.42% |
2020 | $0.60 B | 116.52% |
2019 | $0.27 B | 18.33% |
2018 | $0.23 B | -38.81% |
2017 | $0.38 B | 345.59% |
2016 | $86.54 M |
On Apr 25th, 2024 the market cap of Pulse Biosciences was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
PAVmed
PAVM | $16.23 M | -95.61% | ๐บ๐ธ USA |
Philips PHG | $19.03 B | 5,051.76% | ๐ณ๐ฑ Netherlands |